Report overview
This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy Product. This report contains market size and forecasts of Cellular and Gene Therapy Product in global, including the following market information:
Global Cellular and Gene Therapy Product Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cellular and Gene Therapy Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cellular Immunotherapies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cellular and Gene Therapy Product include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cellular and Gene Therapy Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular and Gene Therapy Product Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, by Type, 2022 (%)
Cellular Immunotherapies
Cancer Vaccines
Autologous and Allogeneic Cells
Global Cellular and Gene Therapy Product Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Prostate Cancer
Skin Cancer
Other
Global Cellular and Gene Therapy Product Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular and Gene Therapy Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cellular and Gene Therapy Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
New York Blood Center
Johnson & Johnson
Cleveland Cord Blood Center
Organogenesis
Duke University School of Medicine
Colorado Cord Blood Banking
MD Anderson Cancer Center
LifeSouth Community Blood Centers
Bloodworks Northwest
Amgen
Novartis Pharmaceuticals
Castle Creek Biosciences
Spark Therapeutics
Vericel
Dendreon Pharmaceuticals
Enzyvant Therapeutics GmbH
Mallinckrodt
Gilead Sciences
bluebird bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cellular and Gene Therapy Product, market overview.
Chapter 2: Global Cellular and Gene Therapy Product market size in revenue.
Chapter 3: Detailed analysis of Cellular and Gene Therapy Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cellular and Gene Therapy Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
